• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心室功能障碍患者中,超出肺循环的新型心血管磁共振转运时间的预后价值。

Prognostic value of novel cardiovascular magnetic resonance transit times beyond the pulmonary circulation in patients with ventricular dysfunction.

作者信息

Sevilla Teresa, Baladrón Carlos, de Miguel-Álava María, Rojas-Lavado Gino, González-Bartol Esther, Revilla-Orodea Ana, Aristizabal-Duque Cristhian, Carrasco-Moraleja Manuel, Fernández-Garrote Miguel, San Román J Alberto

机构信息

Cardiology Department, Hospital Clínico Universitario de Valladolid, Ramón y Cajal 3, 47003, Valladolid, Spain.

Centro de Investigación Biomédica en Red, CIBER-CV, Monforte de Lemos 3-5, 28029, Madrid, Spain.

出版信息

Eur Radiol. 2025 Apr;35(4):2180-2188. doi: 10.1007/s00330-024-11045-3. Epub 2024 Aug 30.

DOI:10.1007/s00330-024-11045-3
PMID:39214894
Abstract

OBJECTIVES

To evaluate the prognostic value of transit time (TT) assessment in the systemic circulation and organ perfusion in patients with ventricular dysfunction (VD). The primary endpoint was defined as death, heart failure admission, or ventricular arrhythmias, and the secondary endpoint was worsening renal function.

METHODS

A retrospective study on 139 patients who underwent cardiac magnetic resonance for VD evaluation and 50 controls. TT was measured as peak-to-peak time in signal intensity over time curves obtained at different stages of circulation (right cavities, left cavities, aorta, and peripheral organs) from first-pass perfusion images. Outcomes were monitored over a median follow-up of 15 months.

RESULTS

A total of 139 patients were included (84% male, age 63 [57-70] years). Patients exhibited significantly prolonged TT compared to controls, with in-patients showing longer times than outpatients. Among the 29 patients reaching the primary endpoint, both PTT and STT were significantly prolonged (PTT: 9.75 s vs 13.4 s, p < 0.01; STT: 4.77 s vs 7.00 s, p < 0.01). Concurrent prolongation of PTT (> 10 s) and STT (> 5 s) was associated with a higher event probability (42.3%), compared to isolated abnormalities (6.3% for PTT, 6.7% for STT). Multivariate analysis revealed that combined PTT and STT alteration independently predicted the combined endpoint (HR IC 95%: 8.685 (2.415-31.236), p = 0.001). Prolonged RPT was independently associated with renal function deterioration (OR IC 95%: 1.129 (1.015-1.256), p = 0.024).

CONCLUSIONS

Evaluation of TT beyond pulmonary circulation provides prognostic insights into VD. Simultaneous assessment of PTT and STT enhances specificity compared to isolated PTT evaluation, predicting combined adverse events. RPT is independently associated with renal impairment.

CLINICAL RELEVANCE STATEMENT

For the first time, it is described that transit time can be evaluated in systemic circulation and in peripheral organs and that this assessment can be easily made from conventional CMR perfusion images and holds significant prognostic value.

KEY POINTS

Pulmonary transit time is a valuable hemodynamic parameter; systemic transit time may also be valuable. Transit time can be measured in the systemic circulation, and is longer in patients with ventricular dysfunction. Systemic transit time assessed by magnetic resonance imaging identifies patients with ventricular dysfunction who will experience events during follow-up.

摘要

目的

评估心室功能不全(VD)患者体循环和器官灌注中通过时间(TT)评估的预后价值。主要终点定义为死亡、心力衰竭入院或室性心律失常,次要终点为肾功能恶化。

方法

对139例接受心脏磁共振成像以评估VD的患者及50例对照者进行回顾性研究。TT通过首次通过灌注图像在循环不同阶段(右心腔、左心腔、主动脉和外周器官)获得的信号强度随时间曲线中的峰峰值时间来测量。在中位随访15个月期间监测结局。

结果

共纳入139例患者(84%为男性,年龄63[57 - 70]岁)。与对照组相比,患者的TT显著延长,住院患者的时间长于门诊患者。在达到主要终点的29例患者中,PTT和STT均显著延长(PTT:9.75秒对13.4秒,p<0.01;STT:4.77秒对7.00秒,p<0.01)。与单独异常(PTT为6.3%,STT为6.7%)相比,PTT(>10秒)和STT(>5秒)同时延长与更高的事件概率相关(42.3%)。多变量分析显示,PTT和STT联合改变独立预测联合终点(HR IC 95%:8.685[2.415 - 31.236],p = 0.001)。RPT延长与肾功能恶化独立相关(OR IC 95%:1.129[1.015 - 1.256],p = 0.024)。

结论

评估肺循环以外的TT可为VD提供预后见解。与单独评估PTT相比,同时评估PTT和STT可提高特异性,预测联合不良事件。RPT与肾功能损害独立相关。

临床相关性声明

首次描述了可在体循环和外周器官中评估通过时间,且该评估可通过传统CMR灌注图像轻松进行,并具有重要的预后价值。

关键点

肺通过时间是一个有价值的血流动力学参数;体循环通过时间可能也有价值。通过时间可在体循环中测量,在心室功能不全患者中更长。通过磁共振成像评估的体循环通过时间可识别在随访期间将发生事件的心室功能不全患者。

相似文献

1
Prognostic value of novel cardiovascular magnetic resonance transit times beyond the pulmonary circulation in patients with ventricular dysfunction.心室功能障碍患者中,超出肺循环的新型心血管磁共振转运时间的预后价值。
Eur Radiol. 2025 Apr;35(4):2180-2188. doi: 10.1007/s00330-024-11045-3. Epub 2024 Aug 30.
2
Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.心脏磁共振肺通过时间对射血分数降低的晚期心力衰竭患者死亡率和心力衰竭住院的预后价值。
Circ Cardiovasc Imaging. 2021 Jan;14(1):e011680. doi: 10.1161/CIRCIMAGING.120.011680. Epub 2021 Jan 13.
3
Pulmonary transit time is a predictor of outcomes in heart failure: a cardiovascular magnetic resonance first-pass perfusion study.肺通过时间是心力衰竭预后的预测因子:一项心血管磁共振首过灌注研究。
BMC Cardiovasc Disord. 2024 Jun 28;24(1):329. doi: 10.1186/s12872-024-04003-w.
4
Prognostic Value of Pulmonary Transit Time and Pulmonary Blood Volume Estimation Using Myocardial Perfusion CMR.利用心肌灌注 CMR 评估肺通过时间和肺血容量的预后价值。
JACC Cardiovasc Imaging. 2021 Nov;14(11):2107-2119. doi: 10.1016/j.jcmg.2021.03.029. Epub 2021 May 19.
5
Prognostic value of pulmonary transit time by cardiac magnetic resonance imaging in ST-elevation myocardial infarction.心脏磁共振成像中肺通过时间对 ST 段抬高型心肌梗死的预后价值。
Eur Radiol. 2023 Feb;33(2):1219-1228. doi: 10.1007/s00330-022-09050-5. Epub 2022 Aug 18.
6
Cardiac Magnetic Resonance Evaluation of Pulmonary Transit Time and Blood Volume in Adult Congenital Heart disease.心脏磁共振评估成人先天性心脏病肺动脉通过时间和血容量。
J Magn Reson Imaging. 2019 Sep;50(3):779-786. doi: 10.1002/jmri.26684. Epub 2019 Mar 5.
7
Pulmonary Transit Time Derived from First-Pass Perfusion Cardiac MR Imaging: A Potential New Marker for Cardiac Involvement and Prognosis in Light-Chain Amyloidosis.基于首过灌注心脏 MRI 的肺通过时间:轻链淀粉样变中心脏受累和预后的一个潜在新标志物。
J Magn Reson Imaging. 2024 Sep;60(3):999-1010. doi: 10.1002/jmri.29135. Epub 2023 Nov 16.
8
Prolonged central circulation transit time in patients with HFpEF and HFrEF by magnetic resonance imaging.磁共振成像显示 HFpEF 和 HFrEF 患者的中央循环转运时间延长。
Eur Heart J Cardiovasc Imaging. 2018 Mar 1;19(3):339-346. doi: 10.1093/ehjci/jex051.
9
Stress pulmonary circulation parameters assessed by a cardiovascular magnetic resonance in patients after a heart transplant.心脏移植后患者的心血管磁共振评估的应激肺循环参数。
Sci Rep. 2022 Apr 12;12(1):6130. doi: 10.1038/s41598-022-09739-z.
10
Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study.首过对比增强 CMR 测定的肺血容积对心力衰竭门诊患者的预后价值:PROVE-HF 研究。
Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):896-904. doi: 10.1093/ehjci/jex214.

本文引用的文献

1
Association of pulmonary transit time by cardiac magnetic resonance with heart failure hospitalization in a large prospective cohort with diverse cardiac conditions.心脏磁共振肺通过时间与多种心脏疾病大型前瞻性队列中心衰住院的相关性。
J Cardiovasc Magn Reson. 2023 Oct 12;25(1):57. doi: 10.1186/s12968-023-00963-8.
2
Pulmonary transit time of cardiovascular magnetic resonance perfusion scans for quantification of cardiopulmonary haemodynamics.心血管磁共振灌注扫描的肺通过时间用于心肺血液动力学定量评估。
Eur Heart J Cardiovasc Imaging. 2023 Jul 24;24(8):1062-1071. doi: 10.1093/ehjci/jead001.
3
Prognostic value of pulmonary transit time by cardiac magnetic resonance imaging in ST-elevation myocardial infarction.
心脏磁共振成像中肺通过时间对 ST 段抬高型心肌梗死的预后价值。
Eur Radiol. 2023 Feb;33(2):1219-1228. doi: 10.1007/s00330-022-09050-5. Epub 2022 Aug 18.
4
First-pass perfusion cardiovascular magnetic resonance parameters as surrogate markers for left ventricular diastolic dysfunction: a validation against cardiac catheterization.首过灌注心血管磁共振参数作为左心室舒张功能障碍的替代标志物:与心导管术的对照验证。
Eur Radiol. 2022 Dec;32(12):8131-8139. doi: 10.1007/s00330-022-08938-6. Epub 2022 Jul 2.
5
Quantitative renal magnetic resonance imaging: magnetic resonance urography.定量肾脏磁共振成像:磁共振尿路成像。
Pediatr Radiol. 2022 Feb;52(2):228-248. doi: 10.1007/s00247-021-05264-9. Epub 2022 Jan 13.
6
Prognostic Value of Pulmonary Transit Time and Pulmonary Blood Volume Estimation Using Myocardial Perfusion CMR.利用心肌灌注 CMR 评估肺通过时间和肺血容量的预后价值。
JACC Cardiovasc Imaging. 2021 Nov;14(11):2107-2119. doi: 10.1016/j.jcmg.2021.03.029. Epub 2021 May 19.
7
Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.心脏磁共振肺通过时间对射血分数降低的晚期心力衰竭患者死亡率和心力衰竭住院的预后价值。
Circ Cardiovasc Imaging. 2021 Jan;14(1):e011680. doi: 10.1161/CIRCIMAGING.120.011680. Epub 2021 Jan 13.
8
Automated detection of left ventricle in arterial input function images for inline perfusion mapping using deep learning: A study of 15,000 patients.使用深度学习在动脉输入功能图像中自动检测左心室以进行在线灌注成像:对15000名患者的研究
Magn Reson Med. 2020 Nov;84(5):2788-2800. doi: 10.1002/mrm.28291. Epub 2020 May 7.
9
"Myocardial transit-time" (MyoTT): a novel and easy-to-perform CMR parameter to assess microvascular disease.心肌通过时间(MyoTT):一种新型且易于操作的 CMR 参数,用于评估微血管疾病。
Clin Res Cardiol. 2020 Apr;109(4):488-497. doi: 10.1007/s00392-019-01530-x. Epub 2019 Jul 18.
10
Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study.首过对比增强 CMR 测定的肺血容积对心力衰竭门诊患者的预后价值:PROVE-HF 研究。
Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):896-904. doi: 10.1093/ehjci/jex214.